Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Amyloid precursor protein secretases comprise several membrane-associated proteolytic enzymes that regulate critical steps in neural health via controlled cleavage events on APP—with dysregulation directly linked to Alzheimer's disease pathogenesis through overproduction/accumulation of toxic amyloids.
Inhibition of secretase activity to reduce Aβ production
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Amyloid Precursor Protein Secretase (APP Secretase).